Ind-Swift Laboratories (NSE:INDSWFTLAB) Long-Term Capital Lease Obligation : ₹0 Mil (As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

What is Ind-Swift Laboratories Long-Term Capital Lease Obligation?

Ind-Swift Laboratories's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₹0 Mil.

Ind-Swift Laboratories's quarterly Long-Term Capital Lease Obligation increased from Jun. 2023 (₹0 Mil) to Sep. 2023 (₹5 Mil) but then declined from Sep. 2023 (₹5 Mil) to Dec. 2023 (₹0 Mil).

Ind-Swift Laboratories's annual Long-Term Capital Lease Obligation increased from Mar. 2021 (₹5 Mil) to Mar. 2022 (₹5 Mil) and increased from Mar. 2022 (₹5 Mil) to Mar. 2023 (₹5 Mil).

Ind-Swift Laboratories Long-Term Capital Lease Obligation Historical Data

The historical data trend for Ind-Swift Laboratories's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ind-Swift Laboratories Long-Term Capital Lease Obligation Chart

Ind-Swift Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

4.61

4.82

5.06

5.33

Ind-Swift Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															-	5.33	-	5.14	-

Ind-Swift Laboratories (NSE:INDSWFTLAB) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Ind-Swift Laboratories Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Ind-Swift Laboratories's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Ind-Swift Laboratories (NSE:INDSWFTLAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ind-Swift Laboratories Ltd (NSE:INDSWFTLAB) » Definitions » Long-Term Capital Lease Obligation

Traded in Other Exchanges

532305:India

Address

SCO 850, Shivalik Enclave, NAC, Manimajra, Chandigarh, PB, IND, 160 101

Website

https://www.indswiftlabs.com

Ind-Swift Laboratories Ltd is engaged in the business of active pharmaceutical ingredients (API). The company caters to diverse therapeutic segments namely Cardiovascular health, Antihistamine, Antidiabetic, Antipsychotic, Parkinson's Disease, Antineoplastic, ADHD Symptoms, Analgesics, Alcohol Abstinence, and Bone Resorption Inhibitor. Geographically, it derives a majority of revenue from Outside India.

Ind-Swift Laboratories (NSE:INDSWFTLAB) Headlines

No Headlines